Analyst Price Targets — ARDT
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| March 9, 2026 8:08 pm | Ben Hendrix | RBC Capital | $13.00 | $9.17 | StreetInsider | Ardent Health Partners Inc (ARDT) PT Lowered to $13 at RBC Capital |
| December 18, 2025 1:13 pm | — | UBS | $14.00 | $8.94 | TheFly | Ardent Health price target lowered to $14 from $14.50 at UBS |
| December 18, 2025 12:06 pm | Ann Hynes | Mizuho Securities | $12.00 | $8.94 | TheFly | Ardent Health price target lowered to $12 from $20 at Mizuho |
| November 18, 2025 11:51 am | — | Mizuho Securities | $13.00 | $8.70 | TheFly | Ardent Health price target lowered to $13 from $20 at Mizuho |
| November 14, 2025 8:59 pm | Whit Mayo | Leerink Partners | $16.00 | $9.01 | TheFly | Ardent Health price target lowered to $16 from $23 at Leerink |
| November 14, 2025 1:30 pm | — | Truist Financial | $13.00 | $8.92 | TheFly | Ardent Health price target lowered to $13 from $21 at Truist |
| November 14, 2025 1:27 pm | Ben Hendrix | RBC Capital | $16.00 | $8.97 | StreetInsider | Ardent Health Partners Inc (ARDT) PT Lowered at RBC Capital Amid Near-Term Headwind |
| November 14, 2025 10:11 am | — | Morgan Stanley | $12.00 | $9.30 | TheFly | Ardent Health downgraded to Equal Weight from Overweight at Morgan Stanley |
| October 14, 2025 9:02 am | — | Goldman Sachs | $19.00 | $14.13 | TheFly | Ardent Health initiated with a Neutral at Goldman Sachs |
| September 10, 2025 9:02 am | — | UBS | $17.00 | $13.03 | TheFly | Ardent Health initiated with a Buy at UBS |
Latest News for ARDT
BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that it will issue its second quarter 2026 results after the market closes on Tuesday, August 4, 2026. A conference call will be held the following day, Wednesday, August 5, 2026, at 10 a.m. ET to review the Company's financial results and conduct a…
Investors need to pay close attention to ARDT stock based on the movements in the options market lately.
Robert DeMichiei acquired 11,260 shares on June 5, 2026, for a transaction value of approximately ~$98,000 at around $8.73 per share. This purchase increased DeMichiei's direct holdings by 46%, bringing his total direct ownership to 35,564 shares post-transaction.
Ardent Health, Inc. (ARDT) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health (NYSE: ARDT) (“Ardent Health” or the “Company”), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that Dave Caspers has been appointed President and Chief Executive Officer, effective immediately. Mr. Caspers, who previously served as Chief Operating Officer, succeeds Marty Bonick, who has stepped down to pursue…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ARDT.
U.S. House Trading
No House trades found for ARDT.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.